Click here to get full coverage on Personalis (NASDAQ:PSNL) delivers shareholders splendid 54% CAGR over 3 years, surging 15% in the last week alone - simplywall.st

Personalis (NASDAQ:PSNL) delivers shareholders splendid 54% CAGR over 3 years, surging 15% in the last week alone  simplywall.st

Personalis (NASDAQ:PSNL) delivers shareholders splendid 54% CAGR over 3 years, surging 15% in the last week alone - simplywall.st

Click here to get full coverage on Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL) - Yahoo Finance

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL)  Yahoo Finance

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL) - Yahoo Finance

Click here to get full coverage on TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU - TipRanks

TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU  TipRanks

TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU - TipRanks

Click here to get full coverage on Insider Sale: CFO AND COO of $PSNL Sells 103,668 Shares - Quiver Quantitative

Insider Sale: CFO AND COO of $PSNL Sells 103,668 Shares  Quiver Quantitative

Insider Sale: CFO AND COO of $PSNL Sells 103,668 Shares - Quiver Quantitative

Click here to get full coverage on Personalis: A Growth Inflection Is Imminent, Hold - Seeking Alpha

Personalis: A Growth Inflection Is Imminent, Hold  Seeking Alpha

Personalis: A Growth Inflection Is Imminent, Hold - Seeking Alpha

Click here to get full coverage on Personalis (PSNL) Moves 20.5% Higher: Will This Strength Last? - Nasdaq

Personalis (PSNL) Moves 20.5% Higher: Will This Strength Last?  Nasdaq

Personalis (PSNL) Moves 20.5% Higher: Will This Strength Last? - Nasdaq

Click here to get full coverage on Personalis (NASDAQ:PSNL) Sees Strong Trading Volume - Here's Why - MarketBeat

Personalis (NASDAQ:PSNL) Sees Strong Trading Volume - Here's Why  MarketBeat

Personalis (NASDAQ:PSNL) Sees Strong Trading Volume - Here's Why - MarketBeat

Click here to get full coverage on Personalis (PSNL) Faces Persistent Losses and High Valuation as Revenue Growth Outpaces Market - Yahoo Finance

Personalis (PSNL) Faces Persistent Losses and High Valuation as Revenue Growth Outpaces Market  Yahoo Finance

Personalis (PSNL) Faces Persistent Losses and High Valuation as Revenue Growth Outpaces Market - Yahoo Finance

Click here to get full coverage on $PSNL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

$PSNL stock is down 10% today. Here's what we see in our data.  Quiver Quantitative

$PSNL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st

Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153%  simplywall.st

Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st

Click here to get full coverage on Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of "Moderate Buy" by Brokerages  MarketBeat

Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on BTIG Maintains Personalis (PSNL) Buy Recommendation - Nasdaq

BTIG Maintains Personalis (PSNL) Buy Recommendation  Nasdaq

BTIG Maintains Personalis (PSNL) Buy Recommendation - Nasdaq

Click here to get full coverage on With 42% ownership, Personalis, Inc. (NASDAQ:PSNL) has piqued the interest of institutional investors - Yahoo Finance

With 42% ownership, Personalis, Inc. (NASDAQ:PSNL) has piqued the interest of institutional investors  Yahoo Finance

With 42% ownership, Personalis, Inc. (NASDAQ:PSNL) has piqued the interest of institutional investors - Yahoo Finance

Click here to get full coverage on $PSNL stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

$PSNL stock is up 8% today. Here's what we see in our data.  Quiver Quantitative

$PSNL stock is up 8% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Personalis, Inc. (NASDAQ:PSNL) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance

Personalis, Inc. (NASDAQ:PSNL) Just Reported And Analysts Have Been Lifting Their Price Targets  Yahoo Finance

Personalis, Inc. (NASDAQ:PSNL) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance

Click here to get full coverage on PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings - Quiver Quantitative

PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings  Quiver Quantitative

PERSONALIS Earnings Results: $PSNL Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Earnings To Watch: Personalis Inc (PSNL) Reports Q3 2025 Result - Yahoo Finance

Earnings To Watch: Personalis Inc (PSNL) Reports Q3 2025 Result  Yahoo Finance

Earnings To Watch: Personalis Inc (PSNL) Reports Q3 2025 Result - Yahoo Finance

Click here to get full coverage on Personalis Inc (PSNL) Q3 2025 Earnings Call Highlights: Strong Clinical Adoption Amid Revenue ... - Yahoo Finance

Personalis Inc (PSNL) Q3 2025 Earnings Call Highlights: Strong Clinical Adoption Amid Revenue ...  Yahoo Finance

Personalis Inc (PSNL) Q3 2025 Earnings Call Highlights: Strong Clinical Adoption Amid Revenue ... - Yahoo Finance

Click here to get full coverage on Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance

Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Yahoo Finance

Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires?  Yahoo Finance

Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires? - Yahoo Finance

Click here to get full coverage on Personalis, Inc.'s (NASDAQ:PSNL) P/S Is Still On The Mark Following 46% Share Price Bounce - simplywall.st

Personalis, Inc.'s (NASDAQ:PSNL) P/S Is Still On The Mark Following 46% Share Price Bounce  simplywall.st

Personalis, Inc.'s (NASDAQ:PSNL) P/S Is Still On The Mark Following 46% Share Price Bounce - simplywall.st

Click here to get full coverage on Personalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Personalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Moderate Buy" by Brokerages  MarketBeat

Personalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on Personalis (PSNL): Revenue Forecast to Grow 30% Annually, But Losses Continue to Mount - simplywall.st

Personalis (PSNL): Revenue Forecast to Grow 30% Annually, But Losses Continue to Mount  simplywall.st

Personalis (PSNL): Revenue Forecast to Grow 30% Annually, But Losses Continue to Mount - simplywall.st

Click here to get full coverage on Personalis (NASDAQ: PSNL) wins Medicare coverage for NeXT Personal in II–III breast cancer - Stock Titan

Personalis (NASDAQ: PSNL) wins Medicare coverage for NeXT Personal in II–III breast cancer  Stock Titan

Personalis (NASDAQ: PSNL) wins Medicare coverage for NeXT Personal in II–III breast cancer - Stock Titan

Click here to get full coverage on These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat - simplywall.st

These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat  simplywall.st

These Analysts Think Personalis, Inc.'s (NASDAQ:PSNL) Sales Are Under Threat - simplywall.st

Click here to get full coverage on Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors - Business Wire

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors  Business Wire

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors - Business Wire

Click here to get full coverage on New Analyst Forecast: $PSNL Given $10.0 Price Target - Quiver Quantitative

New Analyst Forecast: $PSNL Given $10.0 Price Target  Quiver Quantitative

New Analyst Forecast: $PSNL Given $10.0 Price Target - Quiver Quantitative

Click here to get full coverage on Is Personalis (NASDAQ:PSNL) A Risky Investment? - simplywall.st

Is Personalis (NASDAQ:PSNL) A Risky Investment?  simplywall.st

Is Personalis (NASDAQ:PSNL) A Risky Investment? - simplywall.st

Click here to get full coverage on New Analyst Forecast: $PSNL Given $11.0 Price Target - Quiver Quantitative

New Analyst Forecast: $PSNL Given $11.0 Price Target  Quiver Quantitative

New Analyst Forecast: $PSNL Given $11.0 Price Target - Quiver Quantitative

Click here to get full coverage on Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus

Personalis (PSNL) Rating Maintained and Price Target Raised by M  GuruFocus

Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus

Click here to get full coverage on Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st

Insiders Of Personalis Make A Tidy Sum Selling At US$7.14  simplywall.st

Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st

Click here to get full coverage on Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire

Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference  Business Wire

Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference - Business Wire

Click here to get full coverage on PSNL: BTIG Raises Price Target by 83.33% to $11.00 | PSNL Stock News - GuruFocus

PSNL: BTIG Raises Price Target by 83.33% to $11.00 | PSNL Stock News  GuruFocus

PSNL: BTIG Raises Price Target by 83.33% to $11.00 | PSNL Stock News - GuruFocus

Click here to get full coverage on Personalis' MRD Breakthrough Potential: Why I Hold Until Reimbursement Clarity Emerges - Seeking Alpha

Personalis' MRD Breakthrough Potential: Why I Hold Until Reimbursement Clarity Emerges  Seeking Alpha

Personalis' MRD Breakthrough Potential: Why I Hold Until Reimbursement Clarity Emerges - Seeking Alpha

Click here to get full coverage on Personalis, Inc. Announces $100 Million Stock Offering - TradingView — Track All Markets

Personalis, Inc. Announces $100 Million Stock Offering  TradingView — Track All Markets

Personalis, Inc. Announces $100 Million Stock Offering - TradingView — Track All Markets

Click here to get full coverage on New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer  Business Wire

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire

Click here to get full coverage on How the Story Behind Personalis Is Evolving After New Earnings and Guidance Updates - Yahoo Finance

How the Story Behind Personalis Is Evolving After New Earnings and Guidance Updates  Yahoo Finance

How the Story Behind Personalis Is Evolving After New Earnings and Guidance Updates - Yahoo Finance

Click here to get full coverage on How the Narrative Around Personalis Is Shifting After Recent Analyst Updates and Clinical Progress - Yahoo Finance

How the Narrative Around Personalis Is Shifting After Recent Analyst Updates and Clinical Progress  Yahoo Finance

How the Narrative Around Personalis Is Shifting After Recent Analyst Updates and Clinical Progress - Yahoo Finance

Click here to get full coverage on Personalis Reports Second Quarter 2025 Financial Results - Business Wire

Personalis Reports Second Quarter 2025 Financial Results  Business Wire

Personalis Reports Second Quarter 2025 Financial Results - Business Wire

Click here to get full coverage on Institutional investors have a lot riding on Personalis, Inc. (NASDAQ:PSNL) with 42% ownership - simplywall.st

Institutional investors have a lot riding on Personalis, Inc. (NASDAQ:PSNL) with 42% ownership  simplywall.st

Institutional investors have a lot riding on Personalis, Inc. (NASDAQ:PSNL) with 42% ownership - simplywall.st

Click here to get full coverage on Personalis, Inc. (NASDAQ:PSNL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50 - simplywall.st

Personalis, Inc. (NASDAQ:PSNL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50  simplywall.st

Personalis, Inc. (NASDAQ:PSNL) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50 - simplywall.st

Click here to get full coverage on Personalis Reports Third Quarter 2025 Financial Results - Yahoo Finance

Personalis Reports Third Quarter 2025 Financial Results  Yahoo Finance

Personalis Reports Third Quarter 2025 Financial Results - Yahoo Finance

Click here to get full coverage on Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize

Personalis Outpaces The Market With Cancer Test Breakthroughs  Finimize

Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize

Click here to get full coverage on Personalis stock jumps 28% on Medicare coverage for cancer test - Investing.com

Personalis stock jumps 28% on Medicare coverage for cancer test  Investing.com

Personalis stock jumps 28% on Medicare coverage for cancer test - Investing.com

Click here to get full coverage on Personalis files prospectus supplement for up to $100 million stock offering - Investing.com

Personalis files prospectus supplement for up to $100 million stock offering  Investing.com

Personalis files prospectus supplement for up to $100 million stock offering - Investing.com

Click here to get full coverage on Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance

Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds  Yahoo Finance

Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance

Click here to get full coverage on Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady - Investing.com

Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady  Investing.com

Earnings call transcript: Personalis Q2 2025 reveals revenue miss, stock steady - Investing.com

Click here to get full coverage on A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9 - 富途牛牛

A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9  富途牛牛

A Quick Look at Today's Ratings for Personalis(PSNL.US), With a Forecast Between $6 to $9 - 富途牛牛

Click here to get full coverage on Ultra-Sensitive Cancer Detection: Personalis Test Predicts Lung Cancer Outcomes 16 Months Earlier - Stock Titan

Ultra-Sensitive Cancer Detection: Personalis Test Predicts Lung Cancer Outcomes 16 Months Earlier  Stock Titan

Ultra-Sensitive Cancer Detection: Personalis Test Predicts Lung Cancer Outcomes 16 Months Earlier - Stock Titan

Click here to get full coverage on H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8.5 - 富途牛牛

H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8.5  富途牛牛

H.C. Wainwright Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8.5 - 富途牛牛

Click here to get full coverage on Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing - Business Wire

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing  Business Wire

Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing - Business Wire

Click here to get full coverage on How rising interest rates impact PSNL stock - July 2025 Movers & Long Hold Capital Preservation Tips - moha.gov.vn

How rising interest rates impact PSNL stock - July 2025 Movers & Long Hold Capital Preservation Tips  moha.gov.vn

How rising interest rates impact PSNL stock - July 2025 Movers & Long Hold Capital Preservation Tips - moha.gov.vn

Click here to get full coverage on Craig-Hallum Initiates Personalis(PSNL.US) With Buy Rating, Announces Target Price $7 - 富途牛牛

Craig-Hallum Initiates Personalis(PSNL.US) With Buy Rating, Announces Target Price $7  富途牛牛

Craig-Hallum Initiates Personalis(PSNL.US) With Buy Rating, Announces Target Price $7 - 富途牛牛

Click here to get full coverage on Personalis Earnings Call: Strategic Gains Amid Revenue Hurdles - The Globe and Mail

Personalis Earnings Call: Strategic Gains Amid Revenue Hurdles  The Globe and Mail

Personalis Earnings Call: Strategic Gains Amid Revenue Hurdles - The Globe and Mail

Click here to get full coverage on Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Can PSNL stock beat analyst upgrades - 2025 Retail Activity & Precise Swing Trade Alerts - moha.gov.vn

Can PSNL stock beat analyst upgrades - 2025 Retail Activity & Precise Swing Trade Alerts  moha.gov.vn

Can PSNL stock beat analyst upgrades - 2025 Retail Activity & Precise Swing Trade Alerts - moha.gov.vn

Click here to get full coverage on TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛

TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8  富途牛牛

TD Cowen Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8 - 富途牛牛

Click here to get full coverage on Needham raises Personalis stock price target to $10 on MRD testing growth - Investing.com

Needham raises Personalis stock price target to $10 on MRD testing growth  Investing.com

Needham raises Personalis stock price target to $10 on MRD testing growth - Investing.com

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Valuation Update: Why PSNL stock is a must watch in 2025 - Quarterly Profit Report & Accurate Buy Signal Notifications - moha.gov.vn

Valuation Update: Why PSNL stock is a must watch in 2025 - Quarterly Profit Report & Accurate Buy Signal Notifications  moha.gov.vn

Valuation Update: Why PSNL stock is a must watch in 2025 - Quarterly Profit Report & Accurate Buy Signal Notifications - moha.gov.vn

Click here to get full coverage on Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session  Benzinga

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Click here to get full coverage on Personalis receives Medicare coverage for NeXT Personal breast cancer test By Investing.com - Investing.com South Africa

Personalis receives Medicare coverage for NeXT Personal breast cancer test By Investing.com  Investing.com South Africa

Personalis receives Medicare coverage for NeXT Personal breast cancer test By Investing.com - Investing.com South Africa

Click here to get full coverage on The Proper Play On Personalis (NASDAQ:PSNL) - Seeking Alpha

The Proper Play On Personalis (NASDAQ:PSNL)  Seeking Alpha

The Proper Play On Personalis (NASDAQ:PSNL) - Seeking Alpha

Click here to get full coverage on 3 Biotech/Healthcare Names Under $10 I Am Buying Now - Seeking Alpha

3 Biotech/Healthcare Names Under $10 I Am Buying Now  Seeking Alpha

3 Biotech/Healthcare Names Under $10 I Am Buying Now - Seeking Alpha

Click here to get full coverage on About Us | Laser Focus World - Personalis to Announce First Quarter 2025 Financial Results - FinancialContent

About Us | Laser Focus World - Personalis to Announce First Quarter 2025 Financial Results  FinancialContent

About Us | Laser Focus World - Personalis to Announce First Quarter 2025 Financial Results - FinancialContent

Click here to get full coverage on Personalis (PSNL) Upgraded to Buy: Here's What You Should Know - Nasdaq

Personalis (PSNL) Upgraded to Buy: Here's What You Should Know  Nasdaq

Personalis (PSNL) Upgraded to Buy: Here's What You Should Know - Nasdaq

Click here to get full coverage on Personalis and Tempus Expand Collaboration to Biopharma - Business Wire

Personalis and Tempus Expand Collaboration to Biopharma  Business Wire

PSNL

Price Chart

Key Statistics

Technicals

About PSNL

Latest News

Personalis (NASDAQ:PSNL) delivers shareholders splendid 54% CAGR over 3 years, surging 15% in the last week alone - simplywall.st

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL) - Yahoo Finance

TEM, KDK, PSNL: Cathie Wood Loads Up on AI Health Tech, Trims SHOP & ROKU - TipRanks

Advanced Charts

Top Gainers

Top Losers